REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Contains Seven Members Including Nitrogen, Carbon And Chalcogen > Chalcogen Double Bonded Directly To A Ring Carbon Which Is Adjacent To The Ring Nitrogen > Polycyclo Ring System Which Contains The Seven-membered Hetero Ring As One Of The Cyclos > Bicyclo Ring System Having The Seven-membered Hetero Ring As One Of The Cyclos Bicyclo Ring System Having The Seven-membered Hetero Ring As One Of The CyclosBicyclo Ring System Having The Seven-membered Hetero Ring As One Of The Cyclos patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027133 - Bicyclic pyrazolyl and imidazolyl compounds and uses thereof The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals. ... 12/14/06 - 20060281730 - Aspartyl protease inhibitors Also disclosed is the method of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases. Also disclosed are methods of treating cognitive or neurodegenerative diseases using the compounds of formula I in combination with a cholinesterase inhibitor or a muscarinic m1 agonist or ... 10/26/06 - 20060241096 - Agent for preventing or treating organ functional disorders and organ dysfunction The present invention provides an agent for preventing or treating organ functional disorders, an agent for preventing or treating organ dysfunction and an agent for preventing or treating obesity and deuteropathy thereof, each of which comprises a compound having an effect of increasing ubiquinone or a salt thereof or a ... 09/07/06 - 20060199796 - Substituted benzofused heterocycles The present invention relates to the compounds of Formula I, their preparation and pharmaceutical compositions comprising them. The compounds and pharmaceutical compositions are useful, for example, for the treatment and prevention of obesity, obesity-related disorders and eating disorders. ... 09/07/06 - 20060199795 - Receptor agonists wherein ring A is an optionally substituted aromatic ring; and ring B′ is a 5- to 8-membered ring having one or more substituents or a salt thereof or a prodrug thereof, which is useful for the treatment of various diseases. ... 07/13/06 - 20060154915 - Substituted biaryl compounds as factor xia inhibitors or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, L, Z, R3, and ring B are as defined herein. The compounds of Formula (I) are useful as selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; for example thrombin, ... 06/29/06 - 20060142265 - Compositions comprising multiple bioactive agents, and methods of using the same In part, the present invention is directed to compositions comprising a FabI inhibitor and at least one other bioactive agent. In another part, the present invention is directed to antibacterial compositions comprising a compound of formulas I-III and at least one other antibacterial agent. ... 03/23/06 - 20060063752 - Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them wherein Ra, Rb, Rc, A, B, C, D, and X are as defined herein, or a tautomer, stereoisomer, or salt thereof, particularly a physiologically acceptable salt thereof. In addition, pharmaceutical compositions comprising an effective amount of a compound of formula (I), methods for the treatment or prophylaxis of benign or ... 11/24/05 - 20050261274 - Lactams substituted by cyclic succinates as inhibitors of abeta protein production to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of Aβ-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of ... 09/29/05 - 20050215539 - 7-aryl 1,5-dihydro-4, 1-benzoxazepin-2(3h)-one derivatives and their use as progesterone receptor modulators wherein R1 to R7, X, and Q are as defined in the specification; or a pharmaceutically acceptable salt thereof. ... ### FreshPatents.com Support |